SCRS Announces PPD and Pfizer as 2021 Eagle Award Recipients
Contact:
SCRS Communications
Society for Clinical Research Sites
410.696.5080 x150
FOR IMMEDIATE RELEASE
SCRS Announces PPD and Pfizer as 2021 Eagle Award Recipients
Hanover, MD, October 6, 2021 – The Society for Clinical Research Sites (SCRS), the trade organization representing global clinical research sites, is pleased to announce the 2021 recipients of the prestigious SCRS Eagle Award. The Eagle Award, sponsored in 2021 by Advarra, recognizes outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through strong site partnerships. Pfizer is this year’s winning sponsor and PPD is the winning contract research organization (CRO).
“Advarra is pleased to sponsor the 2021 SCRS Eagle Awards, recognizing those organizations who fuel clinical research innovation through strong site, CRO, and sponsor relationships,” shared Advarra’s VP of Strategy, Laura Hilty. “At Advarra we are passionate about empowering sites and enabling site-centric research and these organizational partnerships are foundational to clinical research success and fuels industry innovation and progress.”
The selection criteria for finalists included willingness to collaborate on protocol design and execution, availability of staff to support sites, responsive communication, and fair contracting, budgeting, and payment schedules. SCRS site members nominated companies they had worked with in the past year that they felt exemplified these characteristics, and the winning sponsor and CRO were selected based on votes cast from the global site community. The awards were presented at the SCRS Global Site Solutions Summit Eagle Award Gala, which was held at The Diplomat Beach Resort in Hollywood, Florida October 1 – 3, 2021.
Darren Cowan, Area Head, North America at Pfizer accepted the award while commenting, “Clinical research is hard work, and the last two years have shown us what hard looks like. I want to thank all the global clinical research professionals who answered the call of duty for the world. Your commitment to helping others is remarkable and it’s through your dedication that we’re able to keep science moving forward for people everywhere. Thank you.”
“The Eagle Award is one of the most prestigious honors in our industry, and this recognition affirms PPD’s ongoing commitment to create and sustain strong relationships with our site partners,” said David Johnston, Ph.D., executive vice president and global head of clinical development services at PPD. “In close coordination with our site partners and customers, we are committed to upholding the highest standards in clinical trial management to help deliver life-changing therapies for patients. We want to thank the sites and their research teams for their collaborative partnership as we progress our shared vision.”
“Each Eagle Award finalist represents an amazing commitment to ongoing site success. After more than 4,500 votes, SCRS is honored to present the Eagle Award to Pfizer, the sites’ 2021 sponsor of choice and to PPD, the CRO of choice,” says Sean Soth, Vice President of Global Business Partnerships at SCRS. “SCRS applauds the consistent efforts of Pfizer and PPD to sustain strong partnerships with sites. Congratulations to these two companies for earning this prestigious recognition.”
For more information about the SCRS Eagle Awards and Global Site Solutions Summit, visit sitesolutionssummit.com.
###
About Society for Clinical Research Sites
The Society for Clinical Research Sites (SCRS) is a global trade organization founded in 2012 which represents over 9,500 research sites in 47 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. As an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. For more information, visit MySCRS.org.
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
About PPD
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With more than 28,000 professionals worldwide, PPD has conducted clinical trials in more than 100 countries to help customers deliver life-changing therapies to improve health. We apply innovative technologies, therapeutic expertise and a firm commitment to quality to bend the cost and time curve of drug development and optimize value. For more information, visit www.ppd.com.
About Advarra
Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster. For more information, visit advarra.com.
